MATTHEW BALDERSTON: Open Payments
NPI 1316386394 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,782 in 74 payments from 20 companies in 2025. Trend: 2023 $1,672 · 2024 $1,027 · 2025 $1,782
Food & beverage: $1,782
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $266 |
| PFIZER INC. | 10 | $220 |
| AstraZeneca Pharmaceuticals LP | 4 | $220 |
| ABBVIE INC. | 12 | $180 |
| Novo Nordisk Inc | 9 | $171 |
| GlaxoSmithKline, LLC. | 5 | $117 |
| Medtronic, Inc. | 2 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| Abbott Laboratories | 3 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
Products named: MOUNJARO, AIRSUPRA, NURTEC ODT, TRELEGY ELLIPTA, FARXIGA, JARDIANCE, REXULTI, QULIPTA.
Industry payments across VA — which companies pay providers there.
